I took away from the presentation.
-6000mg is the next cohort being dosed at CMAX, (we already knew that we’re within the efficacy range) Reading in between the lines it seems we have the data we need to progress to Phase II. “Pretty soon” with a smile on his face when he said it. Didn’t really give away to much else. I assume we’re still looking for the “ceiling”
-15.8mill in the bank.
-Increased US focus for the next 0-12month
-RCE has the burns trials data but are waiting on the WA government to release it? He said something about it being sponsored by the WA government so its on their time line to release it.
That was really about it. cards held close to his chestAnd we continue to hold..
I took away from the presentation.-6000mg is the next cohort...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $37.22K | 127.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8471 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 17050 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |